Date published
|
Alert
|
Countries
|
13/11/2024 |
Company led medicines recall: EXS Delay Spray Plus, Leeds Trading Company LTC Ltd T/A LTC Healthcare, CLMR(24)A/01 |
UK |
12/11/2024 |
Class 4 Medicines Defect Information: Omeprazole Powder for solution for infusion 40 mg, Viatris UK Healthcare Ltd, EL(24)A/54 |
UK |
07/11/2024 |
Class 4 Medicines Defect Information: Zoledronic Acid Ennogen concentrate for solution for infusion 4mg/5ml, Ennogen Healthcare Limited, EL (24)A/53 |
UK |
29/10/2024 |
Class 2 Medicines Recall: Labetalol Tablets 200mg, Tillomed Laboratories Limited, EL(24)A/52 |
UK |
28/10/2024 |
Class 4 Medicines Defect Information: Parasolve (Paracetamol) effervescent tablets 500mg, Kent Pharma UK, EL(24)A/51 |
UK |
25/10/2024 |
National Patient Safety Alert – DHSC: Shortage of Molybdenum-99/Technetium99m generators |
UK |
24/10/2024 |
UPDATE: Class 3 Medicines Recall: Cyanocobalamin Tablets 50 mcg, Glenmark Pharmaceuticals Europe Ltd, EL(24)A/46 |
UK |
23/10/1024 |
Class 2 Medicines Recall: Phenobarbital Tablets 15mg, Bristol Laboratories Ltd, Bristol Labs, EL(24)A/50 |
UK |
21/10/2024 |
National Patient Safety Alert: UPDATE: Discontinuation of Kay-Cee-L (potassium chloride 375mg/ml) (potassium chloride 5mmol/5ml) syrup |
UK |
21/10/2024 |
Class 4 Medicines Defect Information: Paracetamol Effervescent Tablets 500mg, Kent Pharma UK, EL(24)A/49 |
UK |
10/10/2024 |
Class 4 Medicines Defect Information: Linezolid film-coated tablets 600 mg, Sandoz Ltd., EL(24)A/48 |
UK |
07/10/2024 |
Class 3 Medicines Recall: Trandolapril capsules 2mg and 4mg, Viatris UK Healthcare Ltd, EL(24)A/47 |
UK |
03/10/2024 |
Class 3 Medicines Recall: Cyanocobalamin Tablets 50 mcg, Glenmark Pharmaceuticals Europe Ltd, EL(24)A/46 |
UK |
01/10/2024 |
Class 4 Medicines Defect Information: Rosuvastatin Tablets 20mg, 40mg, Sandoz Ltd., EL(24)A/45 |
UK |
30/09/2024 |
Class 2 Medicines Recall: Oxbryta Tablets (voxelotor) 500mg, Pfizer Limited, EL(24)A/44 |
UK |
26/09/2024 |
Class 4 Medicines Defect Information: Risperidone Tablets 1mg, 2mg, 3mg, Sandoz Ltd., EL(24)A/43 |
UK |
24/09/2024 |
National Patient Safety Alert – NHS England Patient Safety: Risk of oxytocin overdose during labour and childbirth |
UK |
18/09/2024 |
Class 3 Medicines Recall: Eldepryl Tablets (selegiline) 5mg, Orion Pharma (UK) Ltd, EL(24)A/42 |
UK |
17/09/2024 |
Field Safety Notice: Abbvie recall of two batches of Lacri-lube due to potential breach in tube seal |
UK |
12/09/2024 |
Class 3 Medicines Recall: Evorel Sequi, Theramex HQ UK Ltd, EL (24)A/41 |
UK |
04/09/2024 |
Device Safety Information: CPT Hip System Femoral Stem 12/14 Neck Taper: Increased Risk of Postoperative Periprosthetic Femoral Fracture, DSI/2024/007 |
UK |
28/08/2024 |
Device Safety Information: Philips Respironics BiPAP A series ventilators: alarm malfunction and risk of therapy interruptions in ventilators not intended for life-support, DSI/2024/006 |
UK |
27/08/2024 |
Class 4 Medicines Defect Information: Ponstan capsules 250mg & tablets 500mg (mefenamic acid), Chemidex Pharma Ltd, EL(24)A/40 |
UK |
19/08/2024 |
Class 3 Medicines Recall: Fingolimod Hard Capsules 0.5 mg, Glenmark Pharmaceuticals Europe Ltd, EL(24)A/39 |
UK |
15/08/2024 |
Class 2 Medicines Recall: Loperamide Hydrochloride Capsules 2mg, Strides Pharma UK Limited, EL(24)A/38 |
UK |
14/08/2024 |
Class 4 Medicines Defect Information: Trazodone Hydrochloride Capsules 50mg, 100mg & Oral Solution 50mg/5ml, Dawa Limited, EL (24)A/37 |
UK |
12/08/2024 |
Class 4 Medicines Notification: Diflucan Oral Suspension 40mg/ml, Star Pharmaceuticals Limited, EL(24)A36 |
UK |
08/08/2024 |
Class 3 Medicines Recall: Trandolapril Capsules 0.5mg, 2mg, 4mg, Accord-UK Ltd, EL(24)A/35 |
UK |
07/08/2024 |
Class 4 Medicines Defect Information: Omeprazole products, Sandoz Limited, EL(24)A/34 |
UK |
30/07/2024 |
National Patient Safety Alert – DHSC: Shortage of Human Albumin 4.5% and 5% dose vials |
UK |
30/07/2024 |
Class 3 Medicines Recall: Atomoxetine Hard Capsules 10mg, 18mg, 25mg, 10mg, 40mg, 60mg, 80mg & 100mg, Glenmark Pharmaceuticals Europe Ltd, EL(24)A/33 |
UK |
26/07/2024 |
CAS Alert: Shortage of Kay-Cee-L (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup |
UK |
25/07/2024 |
Class 4 Medicines Defect Information: Co-trimoxazole adult suspension 80mg/400mg/5ml, Aspen Pharma Trading Limited, EL (24)A/32 |
UK |
24/07/2024 |
Class 4 Medicines Defect Information: Hartmann’s Solution for Injection BP as Steriflex No. 11 or freeflex, Fresenius Kabi Limited, EL(24)A/31 |
UK |
22/07/2024 |
Class 2 Medicines Recall: Flolan Powder and Solvent for Solution for Infusion 1.5 mg, Glaxo Wellcome UK Limited (trading as GlaxoSmithKline UK), EL(24)A/30 |
UK |
16/07/2024 |
Class 2 Medicines Recall: Pemetrexed Infusion Bag 1000MG/100ML (10mg/ml) & 1100MG/100ML (11mg/ml), Sun Pharma UK Limited, EL(24)A/29 |
UK |
15/07/2024 |
Class 2 Medicines Recall: Gemcitabine PPF Infusion 1800mg/180mL; Gemcitabine PPF Infusion 1600mg/160mL; Irinotecan PPF Infusion 360mg/240mL, Sun Pharma UK Limited, EL(24)A/28 |
UK |
09/07/2024 |
Class 4 Medicines Defect Information: Propantheline Tablets 15mg (Genesis Pharmaceuticals livery), Chelonia Healthcare Limited, EL(24)A/27 |
UK |
04/07/2024 |
Class 2 Medicines Recall: Itraconazole Oral Solution 10mg/ml, Kent Pharma UK, EL(24)A/26 |
UK |
02/07/2024 |
Class 3 Medicines Recall: Atomoxetine Hard Capsules 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg, Accord Healthcare Ltd, EL(24)A/25 |
UK |
24/06/2024 |
Class 4 Medicines Defect Information: Grepid film coated tablets 75 mg (Kent Pharma Livery), PHARMATHEN S.A., EL(24)A/24 |
UK |
18/06/2024 |
Class 3 Medicines Recall: GoResp Digihaler, Teva UK Ltd, EL (24)A/23 |
UK |
17/06/2024 |
Class 4 Medicines Defect Information: Oxcarbazepine Mylan film-coated tablets 150 mg, 300mg, 600mg, Viatris UK Healthcare Ltd, EL (24)A/22 |
UK |
10/06/2024 |
Class 4 Medicines Defect Information: Paracetamol Film-Coated Tablets 500mg, 1000mg, Dawa Limited, EL (24)A/21 |
UK |
06/06/2024 |
Class 2 Medicines Recall: Lamotrigine Desitin Oral Suspension 10mg/ml, Desitin Pharma UK Ltd, EL(24)A/20 |
UK |
05/06/2024 |
Class 3 Medicines Recall: Atomoxetine Capsules 10mg, 18mg, 25mg, 40mg, Neuraxpharm UK Ltd, EL(24)A/19 |
UK |
03/06/2024 |
Class 4 Medicines Defect Information: Betamethasone Valerate Ointment 0.1%, Manx Healthcare Ltd, EL(24)A/18 |
UK |
24/05/2024 |
National Patient Safety Alert – DHSC: Shortage of Pancreatic enzyme replacement therapy (PERT) |
UK |
23/05/2024 |
National Patient Safety Alert – DHSC: Shortage of Orencia ClickJect (abatacept) 125mg/1ml solution for injection pre-filled pens |
UK |
22/05/2024 |
Class 4 Medicines Defect Information: Sodium Chloride Intravenous Infusion BP 0.9% (Freeflex and Freeflex Plus), Fresenius Kabi Limited, EL (24)A/17 |
UK |
22/05/2024 |
Class 3 Medicines Defect Information: Keppra film-coated tablets 500mg, Doncaster Pharma Limited, EL(24)A/15 |
UK |
20/05/2024 |
Class 4 Medicines Defect Information: Trazodone Hydrochloride Oral Solution 50mg/5ml, Cygnus Pharma Ltd, EL (24)A/16 |
UK |
15/05/2024 |
Class 4 Medicines Defect Information: Keppra film-coated tablets 500mg, Doncaster Pharma Limited, EL(24)A/15 (updated to Class 3 Medicines Defect Information 22/05/2024) |
UK |
03/05/2024 |
National Patient Safety Alert – DHSC: Shortage of Erelzi (etanercept) 50mg solution for injection in pre-filled pen |
UK |
02/05/2024 |
CMO Messaging: Influenza season 2023/24: ending the prescribing and supply of antiviral medicines in primary care |
UK |
23/04/2024 |
Class 3 Medicines Recall: Suprefact solution for injection 1 mg/ml (Cheplapharm – Canadian Livery), Neon Healthcare Ltd, EL(24)A/14 |
UK |
23/04/2024 |
Device Safety Information: Symbios ORIGIN® Posterior Stabilised Patient-Matched Total Knee Replacement Device: Risk of Early Revision, DSI/2024/005 |
UK |
16/04/2024 |
Class 3 Medicines Recall: Invokana tablets 300mg, A. Menarini Farmaceutica Internazionale Srl, (Northern Ireland only), EL(24)A/13 |
Northern Ireland |
10/04/2024 |
Class 3 Medicines Recall: Co-Codamol Effervescent Tablets 8/500mg (Key Pharmaceuticals Livery), Accord-UK Ltd, EL (24)A/12 |
UK |
04/04/2024 |
Device Safety Information: Sodium Chloride Solutions for Irrigation, Inhalation, and Eyewash 0.9%: recall from manufacturer Legency Remedies, DSI/2024/004 |
UK |
04/04/2024 |
Class 3 Medicines Recall: OPDIVO concentrate for solution for infusion (nivolumab) 10 mg/mL, Bristol-Myers Squibb Pharmaceuticals Limited, EL(24)A/11 |
UK |
04/04/2024 |
National Patient Safety Alert – MHRA: Reducing risks for transfusion-associated circulatory overload |
UK |
25/03/2024 |
Device Safety Information: Counterfeits and unbranded copies of LifeVac anti-choking devices may fail to work correctly or worsen choking incidents if used, DSI/2024/003 |
UK |
21/03/2024 |
Class 4 Medicines Notification: Sodium Chloride Intravenous Infusion 0.9% Freeflex, Fresenius Kabi Limited, EL (24)A/10 |
UK |
19/03/2024 |
Class 3 Medicines Recall: Oestrogel Pump-Pack 750 micrograms/actuation Gel (estradiol), Besins Healthcare (UK) Ltd, EL (24)A/09 |
UK |
12/03/2024 |
Class 2 Medicines Recall: Sodiofolin solution for injection/infusion (folinic acid 400mg/8ml vial), 50 mg/ml, medac GmbH (t/a medac Pharma LLP), EL(24)A/08 |
UK |
04/03/2024 |
FSN: Sodium Chloride Irrigation Solution 0.9% w/v, Sodium Chloride Eye Wash Solution 0.9% w/v, Sodium Chloride Inhalation Solution 0.9 % w/v, manufactured by the Legency Remedies Pvt. Ltd. |
UK |
26/02/2024 |
National Patient Safety Alert – DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials |
UK |
26/02/2024 |
Class 4 Medicines Defect Information: Concerta XL prolonged release tablets 18mg & 36 mg, Orifarm UK Ltd, EL (24)A/07 |
UK |
21/02/2024 |
CMO Messaging: Valproate: Important New Regulatory Measures For Oversight Of Prescribing To New Patients And Existing Female Patients |
UK |
21/02/2024 |
Class 2 Medicines Recall: Adakveo concentrate for solution for infusion 10 mg/ml, Novartis Pharmaceuticals UK Limited, EL(24)A/06 |
UK |
20/02/2024 |
Drug Safety Update: Codeine linctus (codeine oral solutions): reclassification to prescription-only medicine |
UK |
13/02/2024 |
Class 3 Medicines Recall: Ramipril tablets 1.25mg, Torrent Pharma (UK) Limited, EL(24)A/05 |
UK |
01/02/2024 |
Class 4 Medicines Defect Information: Gepretix Capsules 100mg, Exeltis UK Limited, EL (24)A/04 |
UK |
31/01/2024 |
National Patient Safety Alert – NHS England Patient Safety: Transition to NRFit connectors for intrathecal and epidural procedures, and delivery of regional blocks |
UK |
30/01/2024 |
Class 4 Medicines Defect Information: Pantoprazole Gastro-Resistant Tablets 40 mg, Cadila Pharmaceuticals (UK) Limited, EL (24)A/03 |
UK |
18/01/2024 |
Class 4 Medicines Defect Information: Sugammadex solution for injection (2 ml vial) 100 mg/ml, USV UK Limited, EL(24)A/02 |
UK |
04/01/2024 |
Class 4 Medicines Defect Information: Cozaar film-coated tablets 100mg, Quadrant Pharmaceuticals Ltd, EL(24)A/01 |
UK |
03/01/2024 |
Company-led Food Recall Alert – FSA: Reckitt recalls two infant formula powders because of the possible presence of Cronobacter sakazakii |
UK |
03/01/2024 |
National Patient Safety Alert – DHSC: Shortage of GLP-1 receptor agonists (GLP-1 RA) update |
UK |
14/12/2023 |
CMO Messaging: Influenza Season 2023/24: Use of antiviral medicines |
UK |
14/12/2023 |
Class 3 Medicines Recall: Posaconazole Biocon Gastro-resistant Tablets 100mg, Biocon Pharma UK Ltd., EL(23)A/44 |
UK |
13/12/2023 |
Class 4 Medicines Defect Information: Clobazam Atnahs Oral Suspension 5mg/5ml and 10mg/5ml, Atnahs Pharma UK Limited, EL(23)A/43 |
UK |
08/12/2023 |
National Patient Safety Alert: Potential for inappropriate dosing of insulin when switching insulin degludec (Tresiba) products |
UK |
07/12/2023 |
National Patient Safety Alert: Potential contamination of some carbomer-containing lubricating eye products with Burkholderia cenocepacia – measures to reduce patient risk |
UK |
07/12/2023 |
National Patient Safety Alert: Identified safety risks with the Euroking maternity information system |
UK |
06/12/2023 |
Class 4 Medicines Defect Information: Clarithromycin film-coated tablets 250mg and 500mg, Strandhaven Ltd t/a Somex Pharma, EL (23)A/42 |
UK |
06/12/2023 |
Class 4 Medicines Defect Information: Tramadol Hydrochloride Capsules, Hard, 50mg, Strandhaven Ltd t/a Somex Pharma, EL (23)A/41 |
UK |
04/12/2023 |
Class 4 Medicines Notification: Caramet CR Tablets 25/100mg, Teva UK Ltd, EL(23)A/40 |
UK |
30/11/2023 |
Class 3 Medicines Recall: Fluenz Tetra nasal spray suspension, AstraZeneca UK Ltd., EL(23)A/39 |
UK |
28/11/2023 |
National Patient Safety Alert: Valproate: organisations to prepare for new regulatory measures for oversight of prescribing to new patients and existing female patients |
UK |
24/11/2023 |
Device Safety Information: Specific brands of carbomer eye gel: recall of AACARB eye gel, AACOMER eye gel and PUROPTICS eye gel: potential risk of infection, DSI/2023/11 |
UK |
23/10/2023 |
Class 4 Medicines Defect Information: Zinacef powder for solution for injection or infusion vials (all strengths, including stock in GSK livery), Sandoz Limited, EL (23)A/38 |
UK |
10/10/2023 |
Device Safety Information: SteriFeed Colostrum Collection device and risk of choking due to infant airway occlusion, DSI/2023/010 |
UK |
28/09/2023 |
National Patient Safety Alert – DHSC: Shortage of verteporfin 15mg powder for solution for injection |
UK |
27/09/2023 |
National Patient Safety Alert – DHSC: Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets |
UK |
27/09/2023 |
Class 4 Medicines Defect Information: Paracetamol Capsules 500 mg, Max Remedies Ltd, Max Healthcare, EL (23)A/37 |
UK |
20/09/2023 |
Class 3 Medicines Recall: Trimbow pressurised inhalation solution 87/5/9 mcg, Chiesi Ltd., EL(23)A/36 |
UK |
07/09/2023 |
Company led medicines recall: Gemcitabine solution for infusion 10mg/ml, PL 31750/0062 (single dose infusion bag, 2000mg/200ml), Sun Pharma UK Ltd, CLMR(23)A/06 |
UK |
07/09/2023 |
Class 4 Medicines Defect Information: Duraphat Fluoride Toothpaste 5000ppm (51g), Colgate-Palmolive (U.K.) Limited, EL (23)A/35 |
UK |
05/09/2023 |
Class 3 Medicines Recall: Evorel Sequi, Theramex HQ UK Ltd, EL (23)A/34 |
UK |
31/08/2023 |
Class 4 Medicines Defect Information: Tostran (Testosterone gel 2%), Kyowa Kirin Limited, EL (23)A/33 |
UK |
30/08/2023 |
Class 2 Medicines Recall: Epistatus oromucosal solution, pre-filled syringe (PFS) 2.5 mg, Veriton Pharma Limited, EL(23)A/32 |
UK |
29/08/2023 |
Class 4 Medicines Defect Information: Loceryl Medicated Nail Lacquer 5% w/v (5.0 ml), Galderma (U.K.) Limited, EL (23)A/31 |
UK |
23/08/2023 |
Class 4 Medicines Notification: Irinotecan Hydrochloride Concentrate for Solution for Infusion 20 mg/ml, Accord Healthcare Limited, UK, EL (23)A/30 |
UK |
22/08/2023 |
Class 4 Medicines Notification: Olmesartan medoxomil film coated tablets 10mg, Accord Healthcare Limited, UK, EL (23)A/29 |
UK |
22/08/2023 |
Device Safety Information: Ethypharm Aurum pre-filled syringes are incompatible with some manufactured needle-free connectors: risk of delay in administering potentially lifesaving medication, DSI/2023/008 |
UK |
21/08/2023 |
Class 2 Medicines Recall: Sodiofolin solution for injection/infusion 50 mg/ml (100mg/2ml vial), medac GmbH (t/a medac Pharma LLP), EL (23)A/28 |
UK |
31/07/2023 |
Class 2 Medicines Recall: B. Braun Medical Ltd, Various Products, EL(23)A/27 |
UK |
20/07/2023 |
Class 2 Medicines Recall: Sodiofolin solution for injection/infusion 50 mg/ml (400mg/8ml vial), medac GmbH (t/a medac Pharma LLP),EL (23)A/26 |
UK |
19/07/2023 |
Company led medicines recall: Diltiazem HCI cream 2% [unlicensed medicine], Quantum Pharmaceutical, CLMR (23)A/05 |
UK |
18/07/2023 |
National Patient Safety Alert – DHSC: Shortage of GLP-1 receptor agonists |
UK |
13/07/2023 |
Class 2 Medicines Recall: Sabril film-coated tablets 500mg & Sabril granules for oral solution 500mg, Aventis Pharma Limited (t/a Sanofi), EL(23)A/25 |
UK |
13/07/2023 |
Class 4 Medicines Notification: Various Products, Cipla (UK) Limited and Pharmathen S.A., EL(23)A24 |
UK |
10/07/2023 |
Class 2 Medicines Recall: Labetalol Tablets 200mg, Tillomed Laboratories Limited, EL(23)A/23 |
UK |
04/07/2023 |
Class 2 Medicines Recall: Dacarbazine powder for solution for injection vials 100mg, 200mg & 500mg, medac GmbH (t/a medac Pharma LLP), EL(23)A/22 |
UK |
03/07/2023 |
Class 3 Medicines Recall: Sildenafil film-coated tablets 100mg, Strandhaven Limited T/A Somex Pharma, EL(23)A/21 |
UK |
27/06/2023 |
National Patient Safety Alert: Potential risk of underdosing with calcium gluconate in severe hyperkalaemia |
UK |
06/06/2023 |
Class 3 Medicines Recall: Medical Oxygen B.P (MEDIGAS OXYGEN B.P), Tricodent Limited (supplier), EL (23)A/20 |
UK |
24/05/2023 |
National Patient Safety Alert: Shortage of pyridostigmine tablets 60mg, NatPSA/2023/006/DHSC |
UK |
23/05/2023 |
Class 4 Medicines Defect Information: Metronidazole oral suspension 200 mg/5 ml, Drugsrus Limited / Dawa Limited, EL (23)A/19 |
UK |
22/05/2023 |
Class 4 Medicines Defect Information: Buccolam Oromucosal solution 10mg, Orifarm UK Ltd, EL (23)A/18 |
UK |
16/05/2023 |
Class 4 Medicines Defect Information: Simulect powder and solvent for Solution for injection or infusion 10mg & 20mg, Novartis Pharmaceuticals, EL (23)A/17 |
UK |
10/05/2023 |
Class 3 Medicines Recall: Gemcitabine Solution For Infusion Vial 1g/26.3ml & 2g/52.6ml, Hikma Farmacêutica Portugal S.A., EL(23)A/16 |
UK |
09/05/2023 |
National Patient Safety Alert: Class 1 Medicines Recall Notification: Emerade auto-injectors 500 micrograms and 300 micrograms, NatPSA/2023/004/MHRA |
UK |
26/04/2023 |
Class 4 Medicines Defect Information: Beconase Hayfever Nasal Spray, Omega Pharma Ltd, EL (23)A/15 |
UK |
20/04/2023 |
Class 4 Medicines Defect Information: Co-amoxiclav powder for oral suspension 125/31.25mg/5ml, 250/62.5mg/5ml, Sandoz Limited, EL (23)A/14 |
UK |
20/04/2023 |
Company led medicines recall: Canopy AKH 22 Dried Cannabis 5g [unlicensed medicine], Spectrum Therapeutics UK, CLMR (23)A/04 |
UK |
30/03/2023 |
Class 4 Medicines Defect Information: Briviact film-coated tablets 75mg & 100mg, Ethigen Limited, EL(23)A/13 |
UK |
23/03/2023 |
Class 2 Medicines Recall: Gonapeptyl Depot powder and solvent for suspension for injection 3.75mg, Ferring Pharmaceuticals Limited, EL(23)A/12 |
UK |
21/03/2023 |
Class 3 Medicines Recall: Sildenafil oral suspension 10mg/ml, Rosemont Pharmaceuticals Limited, EL(23)A/11 |
UK |
16/03/2023 |
Class 4 Medicines Defect Information: Venlafaxine XL prolonged-release tablets 150mg, 225mg, 300mg, Macarthys Laboratories t/a Martindale Pharma, EL(23)A/10 |
UK |
14/03/2023 |
Class 2 Medicines Recall: Pholcodine-containing products, various Marketing Authorisation holders, EL (23)A/09 |
UK |
09/03/2023 |
Class 4 Medicines Defect Information: Clexane syringes 10,000 IU (100mg)/1ml, Drugsrus Limited, EL(23)A/08 |
UK |
07/03/2023 |
Class 4 Medicines Defect Information: Methadone oral solution BP 1mg/mL – sugar free, Methadone mixture 1mg/ml , Thornton & Ross Ltd, EL(23)A/07 |
UK |
02/03/2023 |
Class 2 Medicines Recall: Levothyroxine tablets 12.5mcg, Teva UK Limited, EL (23)A/06 |
UK |
27/02/2023 |
Company led medicines recall: Levothyroxine Oral Suspension (Various Strengths) [unlicensed medicine], Vertical Pharma Resources Ltd T/A IPS Pharma, CLMR(23)A/03 |
UK |
27/02/2023 |
Class 4 Medicines Defect Information: Zestoretic tablets 20mg/12.5mg, Atnahs Pharma UK, EL (23)A/05 |
UK |
22/02/2023 |
Class 4 Medicines Defect Information: Lemsip Max Cold and Flu Capsules, Reckitt Benckiser Healthcare (UK) Limited, EL (23)A/04 |
UK |
06/02/2023 |
Field Safety Notice: Abbott voluntary recall of certain FreeStyle Libre® 2 sensors from lot KTP005061 |
UK |
25/01/2023 |
Company led medicines recall: Clopidogrel oral solution 75mg/5ml [unlicensed medicine], Prulab Pharma Limited, CLMR (23)A/02 |
UK |
19/01/2023 |
Class 3 Medicines Recall: Lacidipine film-coated tablets 4 mg, Dr Reddy’s Laboratories (UK) Ltd, EL (23)A/03 |
UK |
18/01/2023 |
Class 2 Medicines Recall: Dioctyl capsules 100mg, UCB Pharma Ltd, EL (23)A/02 |
UK |
12/01/2023 |
Company led medicines recall: Fluphenazin-neuraxpharm® D solution for injection 25 & 100 mg/ml, Mawdsley-Brooks & Company Limited, CLMR(23)A/01 |
UK |
10/01/2023 |
National Patient Safety Alert – Use of oxygen cylinders where patients do not have access to medical gas pipeline systems |
England |
03/01/2023 |
Class 4 Medicines Defect Information: Bylvay hard capsules 1200 micrograms, Albireo AB, EL (23)A/01 |
UK |
19/12/2022 |
Class 4 Medicines Defect Information: Epiduo gel 0.1% / 2.5% (45 g), Galderma (U.K.) Limited, EL (22)A/52 |
UK |
06/12/2022 |
Class 4 Medicines Defect Information: Etrivex shampoo 500 micrograms/g, Galderma (U.K.) Limited, EL (22)A/51 |
UK |
05/12/2022 |
Class 4 Medicines Defect Information: MacroBID prolonged-release capsules 100mg, ADVANZ PHARMA, EL (22)A/50 |
UK |
29/11/2022 |
Class 4 Medicines Defect Information: Oxycodone Hydrochloride oral solution 10mg/ml, Lucis Pharma Ltd, EL (22)A/49 |
UK |
28/11/2022 |
CMO Messaging: Treatments for Highest Risk Non-Hospitalised Patients (Adults and Children) with COVID-19 |
UK |
24/11/2022 |
CMO Messaging: Influenza season 2022/2023: Use of antiviral medicines |
England |
21/11/2022 |
Class 4 Medicines Defect Information: Hyoscine butylbromide film-coated tablets 20 mg, Morningside Healthcare Limited, EL (22)A/48 |
UK |
16/11/2022 |
Class 4 Medicines Defect Information: Venlafaxine XL prolonged-release tablets 300 mg, Macarthys Laboratories t/a Martindale Pharma, EL(22)A/47 |
UK |
10/11/2022 |
National Patient Safety Alert: Class 4 Medicines Defect Information: Prenoxad solution for injection 1mg/ml, Macarthys Laboratories (Aurum Pharmaceuticals Ltd/Ethypharm Group), due to potential missing needles in sealed kits, NatPSA/2022/009/MHRA |
UK |
27/10/2022 |
Class 3 Medicines Recall: Mebeverine hydrochloride film-coated tablets 135mg, Medreich PLC, EL (22)A/46 |
UK |
25/10/2022 |
Class 4 Medicines Defect Information: Recordati Rare Diseases, Pedea 5 mg/ml solution for injection, EL(22)A/45 |
UK |
21/10/2022 |
National Patient Safety Alert: Class 1 Medicines Recall Notification: Targocid powder for solution for injection/infusion or oral solution, 200mg Aventis Pharma Limited t/a Sanofi, NatPSA/2022/008/MHRA |
UK |
20/10/2022 |
Class 2 Medicines Recall: Ephedrine hydrochloride solution for injection 30 mg/ml, hameln pharma ltd, EL(22)A/44 |
UK |
12/10/2022 |
Class 4 Medicines Defect Information: Ibuprofen tablets 400mg, Paracetamol tablets (caplets) 500mg, Flamingo Pharma UK Ltd, EL (22)A/43 |
UK |
11/10/2022 |
Class 2 Medicines Recall: Amiodarone hydrochloride concentrate for solution for injection/infusion 50 mg/ml, hameln pharma ltd, EL (22)A/42 |
UK |
06/10/2022 |
Class 2 Medicines Recall: Stemetil syrup 5mg/5ml, Aventis Pharma Limited (t/a Sanofi), EL(22)A/41 |
UK |
20/09/2022 |
Class 2 Medicines Recall: Sandimmun Oral Solution, Novartis Pharmaceuticals UK, EL(22)A/40 |
UK |
14/09/2022 |
Class 4 Medicines Defect Information: Atorvastatin oral suspension 4mg/ml & Sildenafil oral suspension 10mg/ml, Rosemont Pharmaceuticals Ltd, EL (22)A/39 |
UK |
12/09/2022 |
Class 4 Medicines Defect Information: Bezalip Mono tablets 400mg, Quadrant Pharmaceuticals Limited, EL (22)A/38 |
UK |
22/08/2022 |
Class 2 Medicines Recall: Dysport Powder for Solution for Injection 500 Units, Ipsen Limited, EL(22)A/36 |
UK |
17/08/2022 |
Class 4 Medicines Defect Information: Rosuvastatin film-coated tablets 5 mg, 10 mg and 20 mg, Accord Healthcare, EL (22)A/35 |
UK |
11/08/2022 |
Class 2 Medicines Recall: Zoledronic acid SUN solution for infusion 5mg, Sun Pharmaceutical Industries Europe BV, EL(22)A/34 |
UK |
08/08/2022 |
Company led medicines recall: Sodium Chloride Eye Drops 5% 1x10ml (unlicensed medicine), Stockport Pharmaceuticals, CLMR (22)A/06 |
UK |
04/08/2022 |
National Patient Safety Alert: Class 1 Medicines Recall Notification: Mexiletine hydrochloride hard capsules 50mg, 100mg and 200 mg, Clinigen Healthcare Ltd, NatPSA/2022/007/MHRA |
UK |
29/07/2022 |
National Patient Safety Alert: Philips Health Systems V60, V60 Plus and V680 ventilators: potential unexpected shutdown leading to complete loss of ventilation (NatPSA/2022/002/MHRA) |
UK |
21/07/2022 |
Class 4 Medicines Defect Information: NovoRapid® FlexTouch® 100 units/ml, Saxenda® FlexTouch® (liraglutide) 6mg/ml, Novo Nordisk Limited, EL(22)A/33 |
UK |
20/07/2022 |
Class 4 Medicines Defect Information: Niquitin 14mg Clear Patch (14 patches), Omega Pharma Limited, EL(22)A/32 |
UK |
19/07/2022 |
Class 2 Medicines Recall: Amiodarone hydrochloride concentrate for solution for injection/infusion 50 mg/ml, hameln pharma ltd, EL(22)A/31 |
UK |
14/07/2022 |
Class 4 Medicines Defect Information: Covonia Night Time Formula and Covonia Original Bronchial Balsam, Thornton & Ross, EL(22)A/30 |
UK |
24/06/2022 |
National Patient Safety Alert: Contamination of hygiene products with Pseudomonas aeruginosa |
UK |
22/06/2022 |
Company led medicines recall: Linoforce granules 12 years plus (THR 13668/0021), A.Vogel Ltd, CLMR (22)A/05 |
UK |
16/06/2022 |
Class 4 Medicines Defect Information: Phenylephrine solution for injection/infusion 0.08 mg/ml, Altan Pharma Limited, EL(22)A/29 |
UK |
15/06/2022 |
Company led medicines recall: Ketamine oral solution 50mg/5ml and 100mg/5ml (unlicensed medicines), PCCA Limited, CLMR (22)A/04 |
UK |
13/06/2022 |
Class 2 Medicines Recall: Phenobarbital tablets 60 mg, Bristol Laboratories Limited, EL(22)A/28 |
UK |
01/06/2022 |
Class 4 Medicines Defect Information: OxyContin prolonged release tablets 20 mg, Napp Pharmaceuticals Limited, EL (22)A/27 |
UK |
31/05/2022 |
Class 4 Medicines Defect Information: Esomeprazole powder for solution for injection/infusion 40mg, EL (22)A/26 |
UK |
30/05/2022 |
CMO Messaging: Antivirals or Neutralising Antibodies for Non-Hospitalised Patients with COVID-19 |
England |
30/05/2022 |
Company led medicines recall: Invita D3 soft capsules 800 IU, Consilient Health UK Ltd, CLMR (22)A/03 |
UK |
26/05/2022 |
Class 4 Medicines Defect Information: Loprazolam tablets 1mg, Orifarm UK Ltd, EL (22)A/25 |
UK |
26/05/2022 |
National Patient Safety Alert: NovoRapid PumpCart in the Roche Accu-Chek Insight insulin pump: risk of insulin leakage causing hyperglycaemia and diabetic ketoacidosis (NatPSA/2022/004/MHRA) |
UK |
25/05/2022 |
Class 2 Medicines Recall: Water for Injections BP – 100ml vial, hameln pharma ltd, EL (22)A/24 |
UK |
20/05/2022 |
Class 4 Medicines Defect Information: Zovirax I.V. 500 mg, GlaxoSmithKline UK Ltd, EL (22)A/22 |
UK |
17/05/2022 |
Class 2 Medicines Recall: Mefenamic acid film coated tablets 500mg, Quadrant Pharmaceuticals Ltd, EL (22)A/23 |
UK |
16/05/2022 |
CMO Messaging: Immediate actions in response to cases of Monkeypox Virus in the UK with no known travel history |
England |
09/05/2022 |
Class 4 Medicines Defect Information: Zovirax I.V. 500 mg, GlaxoSmithKline UK Ltd, EL (22)A/22 |
UK |
05/05/2022 |
Class 2 Medicines Recall: Accupro film-coated tablets 5mg, 10mg, 20mg, 40mg, Pfizer Limited, EL(22)A/21 |
UK |
28/07/2022 |
Class 2 Medicines Recall: Sodium bicarbonate solution for infusion 1.26%, Fresenius Kabi Limited, EL(22)A/20 |
UK |
27/04/2022 |
Class 2 Medicines Recall: Paroxetine film coated tablets 40mg, Crescent Pharma Limited, EL(22)A/19 |
UK |
21/04/2022 |
Class 4 Medicines Defect Information: Depo-Medrone with Lidocaine 40 mg/mL (1 mL and 2 mL vials – single vial preparations), Pfizer Limited, EL (22)A/18 |
UK |
11/04/2022 |
Class 2 Medicines Recall: Olopatadine USV 1mg/ml Eye Drops, Solution, USV UK Limited, EL(22)A/17 |
UK |
05/04/2022 |
NPSA: Inadvertent oral administration of potassium permanganate |
England |
28/03/2022 |
Class 2 Medicines Recall: Accuretic film-coated tablets 10/12.5 mg, Pfizer Limited, EL (22)A/16 |
UK |
17/03/2022 |
Class 4 Medicines Defect Information: Benzylpenicillin benzathine powder and solvent for suspension for injection, 1.2 Million I.U. and 2.4 Million I.U., EL (22)A/15 |
UK |
15/03/2022 |
Class 4 Medicines Defect Information: Beclometasone dipropionate Nasal Spray 50 micrograms/dose (Various Liveries), Ayrton Saunders Limited, EL (22)A/14 |
UK |
14/03/2022 |
Class 4 Medicines Defect Information: Latuda film-coated tablets, CNX Therapeutics Ltd, EL (22)A/13 |
UK |
10/03/2022 |
Class 4 Medicines Defect Information: Decongestant Tablets and Decongestant with Pain Relief Tablets, Boots Company Plc, EL (22)A/12 |
UK |
07/03/2022 |
Class 2 Medicines Recall: Diazepam RecTubes 2.5mg Rectal Solution, Wockhardt UK Ltd, EL (22)A/11 |
UK |
04/03/2022 |
National Patient Safety Alert (UKHSA): Potential contamination of Alimentum and Elecare infant formula food products |
England |
02/03/2022 |
Class 3 Medicines Recall: Isotard XL tablets 60mg, Kyowa Kirin Services Ltd., EL (22)A/10 |
UK |
28/02/2022 |
UPDATE: Class 4 Medicines Defect Information: Naprosyn Tablets (all strengths), Naprosyn EC 250mg gastro-resistant tablets, Naprosyn EC 500mg gastro-resistant tablets, Atnahs Pharma UK Limited, EL (22)A/09 |
UK |
23/02/2022 |
Class 4 Medicines Defect Information: Naprosyn tablets (all strengths), Naprosyn EC 500mg gastro-resistant tablets, Atnahs Pharma UK Limited, EL (22)A/09 |
UK |
17/02/2022 |
Class 2 Medicines Recall: Fluorouracil Injection, 50 mg/ml, solution for injection (2500mg/50ml vial), Medac GmbH (t/a Medac Pharma LLP), EL (22)A 08 |
UK |
17/02/2022 |
Class 2 Medicines Recall: Efudix cream 5% w/w, Uni Health Distribution, EL (22)A 07 |
UK |
15/02/2022 |
Class 2 Medicines Recall: Water for Injections BP, 100ml vial, Hameln Pharma ltd, EL (22)A 06 |
UK |
14/02/2022 |
Company led medicines recall: Bucain Hyperbar Solution for Injection 5mg/ml (unlicensed medicine), CLMR (22)A/01 |
UK |
03/02/2022 |
Class 4 Medicines Defect Information: Atnahs Pharma UK Limited, Naprosyn Tablets (all strengths), Naprosyn EC 250mg Gastro-Resistant Tablets, EL (22)A/05 |
UK |
01/02/2022 |
Class 4 Medicines Defect Information: Flamingo Pharma UK Ltd, Ibuprofen 400mg Tablets, EL (22)A/04 |
UK |
31/01/2022 |
Class 4 Medicines Defect Information: Antibiotice SA, Piperacillin / Tazobactam 4g/0.5 g, powder for solution for infusion, EL (22)A/03 |
UK |
25/01/2022 |
Class 4 Medicines Defect Information: Fresenius Kabi Limited, Kabiven Emulsion for Infusion, EL (22)A/02 |
UK |
19/01/2022 |
Class 2 Medicines Recall: SANTEN Oy (trading as Santen UK Limited) IKERVIS eye drops, emulsion, 1 mg/mL, EL (22)A/01 |
UK |
30/12/2021 |
Company led medicines recall: Dermaved Sensitive Cream (unlicensed medicine), CLMR (21)A/09 |
UK |
21/12/2021 |
Class 4 Medicines defect information: Benylin Chesty Coughs Original (P) and Benylin Chesty Coughs Non-Drowsy (GSL), EL(21)A/39 |
UK |
21/12/2021 |
Supply disruption alert: Advanz epoprostenol 0.5mg and 1.5mg powder and solvent (pH10.5) solution for infusion vials |
UK |
20/12/2021 |
Class 2 Medicines Recall: Heparin sodium 1,000 I.U./ml solution for injection or concentrate for solution for infusion, Wockhardt UK Ltd, EL (21)A/38 |
UK |
16/12/2021 |
CMO Messaging: Neutralising monoclonal antibodies in the treatment of COVID-19 in hospitalised patients |
UK |
16/12/2021 |
CMO Messaging: Neutralising monoclonal antibodies (nMABs) or antivirals for non-hospitalised patients with COVID-19 |
UK |
16/12/2021 |
Class 4 Medicines Defect Information: SmofKabiven Central emulsion for Infusion, Fresenius Kabi Ltd, EL (21)A/37 |
UK |
14/12/2021 |
CMO Messaging: Withdrawal of the Recommendation for Consideration of Inhaled Budesonide as a Treatment Option for COVID-19 |
UK |
13/12/2021 |
Class 2 Medicines Recall: Lucentis solution for injection pre-filled syringe 10 mg/ml, 5ml, Novartis Pharmaceuticals UK, EL (21)A/36 |
UK |
08/12/2021 |
Class 2 Medicines Recall: Mydrilate eye drops 0.5% 5ml, Intrapharm Laboratories Ltd, EL (21)A/35 |
UK |
30/11/2021 |
Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products, EL(21)A/34 |
UK |
29/11/2021 |
Class 4 Medicines Defect Information: Mometasone Furoate Nasal Spray, Suspension, 50 Microgram / Dose, PilsCo Ltd, EL (21)A/33 |
UK |
29/11/2021 |
Class 4 Medicines Defect Information: Diuril Oral Solution (unlicensed medicine), Mawdsley-Brooks & Company Limited, EL (21)A/32 |
UK |
28/11/2021 |
CMO messaging: Update on COVID-19 Variant B.1.1.529 |
UK |
26/11/2021 |
CAS Supply disruption alert: Hypovase (prazosin) 500 microgram tablets |
UK |
22/11/2021 |
Class 3 Medicines Recall: Methadone 5mg Tablets / Physeptone 5mg Tablets, Martindale Pharma, an Ethypharm Group Company, EL (21)A/31 |
UK |
18/11/2021 |
Class 2 Medicines Recall: IKERVIS eye drops, emulsion, 1 mg/mL and VERKAZIA eye drops, emulsion, 1 mg/mL, SANTEN Oy (trading as Santen UK Limited) and parallel distributor, EL (21)A/30 |
UK |
17/11/2021 |
Company led medicines recall: Dotarem solution for injection (10ml Vial) – PL 12308/0016 |
UK |
15/11/2021 |
Class 4 Medicines Defect Information: Slenyto prolonged-release tablets 1 mg and 5mg– distributed by Flynn Pharma Ltd, EL (21)A/29 |
UK |
11/11/2021 |
Class 2 Medicines Recall: Cold & Flu Relief Capsules (GSL) – Various Liveries, Wrafton Laboratories Limited (trading as Perrigo), EL (21)A/28 |
UK |
11/11/2021 |
National Patient Safety Alert: The safe use of ultrasound gel to reduce infection risk |
UK |
02/11/2021 |
Class 4 Medicines Defect Information: SyreniRing 0.120 mg/0.015 mg per 24 hours, vaginal delivery system, Crescent Pharma Ltd, EL (20)A/36 |
UK |
28/10/2021 |
Supply Disruption Alert: Champix (varenicline) 0.5mg and 1mg tablets |
England |
26/10/2021 |
Class 3 Medicines Recall: Bimatoprost Aspire 0.3mg/ml eye drops, solution in single-dose container, Aspire Pharma Limited, EL (21)A/26 |
UK |
14/10/2021 |
Class 2 Medicines Recall: Champix (all strengths) film-coated tablets, Pfizer Ltd, EL (21)A/25 |
UK |
12/10/2021 |
Class 2 Medicines Recall: Tesco Flu-Max All In One Chesty Cough & Cold Powder for Oral Solution (Wrafton Laboratoires Limited trading as Perrigo) EL (21)A/24 |
UK |
11/10/2021 |
Supply disruption alert: Diazepam RecTubes® 2.5mg Rectal Solution (Wockhardt UK Ltd), SDA/2021/013 |
UK |
27/09/2021 |
Class 2 Medicines Recall: Levothyroxine tablets 50mcg (Accord UK Ltd, trading as North Star), EL (21)A/23 |
UK |
15/09/2021 |
Class 2 Medicines Recall: IKERVIS eye drops, emulsion, 1 mg/mL, SANTEN Oy (trading as Santen UK Limited), EL (21)A/22 |
UK |
09/09/2021 |
Class 4 Medicines Defect Information: Rosuvastatin film-coated tablets, 5mg, 10mg, 20mg and 40mg, Accord Healthcare (EL (21)A/21) |
UK |
25/08/2021 |
Class 2 Medicines Recall: Metformin Hydrochloride oral solution 500mg/5ml , Rosemont Pharmaceuticals Ltd, PL 00427/0139
|
UK |
25/08/2021 |
National Patient Safety Alert: Infection risk when using FFP3 respirators with valves or Powered Air Purifying Respirators (PAPRs) during surgical and invasive procedures |
England |
25/08/2021 |
National Patient Safety Alert: Elimination of bottles of liquefied phenol 80% |
England |
18/08/2021 |
National Patient Safety Alert: Potent synthetic opioids implicated in increase in drug overdoses |
England |
09/08/2021 |
Class 2 Medicines Recall: Irbesartan-containing products, various Marketing Authorisation Holders and parallel distributor companies, EL (21)A/19 |
UK |
06/08/2021 |
Medicine Supply Alert Notice: Dalacin® (clindamycin) 2% vaginal cream |
Scotland |
06/08/2021 |
Medicine Supply Alert Notice: Kolanticon gel® (2.5mg dicycloverine hydrochloride, 200mg aluminium hydroxide, 100mg light magnesium oxide, 20mg simethicone per 5ml) |
Scotland |
06/08/2021 |
Medicine Supply Alert Notice: Tuberculosis (TB) oral agents |
Scotland |
02/08/2021 |
Supply disruption alert: Glipizide tablets (Minodiab) 5mg |
UK |
29/07/2021 |
Supply disruption alert: Tinzaparin sodium (10,000 IU/ml) 3,500 units in 0.35ml and 4,500 units in 0.45ml pre-filled syringes |
UK |
19/07/2021 |
Class 4 Medicines Defect Notification: Amoxicillin 500 mg/ 5 ml Powder for oral suspension, (PL 25298/0248), EL (21)A/18 |
UK |
12/07/2021 |
Class 4 Medicines Defect Notification: Sevredol tablets10 mg and 20mg, Napp Pharmaceuticals Ltd,(PL 16950/0063, PL 16950/0064), EL (21)A/17 |
UK |
06/07/2021 |
Class 4 Medicines Defect Notification: Tetralysal hard capsules 300mg, Galderma UK (PL 10590/0019), EL (21)A/16 |
UK |
01/07/2021 |
Class 2 Medicines Recall: Xomolix solution for injection 2.5mg/ml, Kyowa Kirin Limited |
UK |
01/07/2021 |
Company led medicines recall: Morphine Syringe 50mg/50ml (unlicensed medicine) and Magnesium Sulphate 8mmol/20ml infusion (unlicensed medicine) |
UK |
25/06/2021 |
Supply disruption alert: Dexamethasone 0.1% (Maxidex) 5ml eye drops |
UK |
24/06/2021 |
Supply disruption alert: Champix (varenicline) tablets 0.5mg and 1mg |
UK |
23/06/2021 |
National Patient Safety Alert: Philips ventilator, CPAP and BiPAP devices: Potential for patient harm due to inhalation of particles and volatile organic compounds |
UK |
17/06/2021 |
Class 2 Medicines Recall: Bristol Laboratories Limited, Brown & Burk UK Ltd, Teva UK Ltd, Irbesartan-containing and Losartan-containing products, EL (21)A/14 |
UK |
16/06/2021 |
Class 1 Medicines Recall Notification: Co-codamol 30/500 Effervescent Tablets, Batch 1K10121, Zentiva Pharma UK Ltd, NatPSA/2021/004/MHRA |
UK |
16/06/2021 |
CAS alert: NatPSA: Eliminating the risk of inadvertent connection to medical air via a flowmeter |
England |
14/06/2021 |
CAS alert: Updated Publication of Remdesivir guidance for patients hospitalised with Covid-19 (adults and children aged 12 years and older) |
England |
09/06/2021 |
Company led medicines recall: Noidecs T20/C4 (THC 20%; CBD <4%) Indica Cannabis Flower (unlicensed medicine) and Noidecs T20/C4 (THC 20%; CBD <4%) Sativa Cannabis Flower (unlicensed medicine) |
UK |
09/06/2021 |
CAS alert: Personal protective equipment and heat: risk of heat stress |
England |
20/05/2021 |
Class 3 Medicines Recall: Carbimazole tablets 10mg and 15mg, Advanz Pharma, EL (21)A/13 |
UK |
19/05/2021 |
National Patient Safety Alert: Urgent assessment/treatment following ingestion of ‘super strong’ magnets |
England |
17/05/2021 |
Class 2 Medicines Recall: Bricanyl Injection, 0.5 mg/ml solution for injection or infusion (PL 17901/0112), AstraZeneca UK Limited, EL (21)A/12 |
UK |
04/05/2021 |
Class 4 Medicines Notification: Syonell gastro-resistant tablets 250mg and 500mg, Lupin Healthcare Ltd, EL (21)A/11 |
UK |
22/04/2021 |
Medicine Supply Alert Notice: Pioglitazone 15mg/metformin 850mg (Competact®) tablets |
Scotland |
22/04/2021 |
Class 2 Medicines Recall: Trimethoprim tablets 200mg, Ennogen Pharma Limited, PL 40147/0083 |
UK |
15/04/2021 |
Medicine Supply Alert Notice: Chloral Hydrate 143.3mg in 5ml oral solution |
Scotland |
15/04/2021 |
Medicine Supply Alert Notice: Diamorphine hydrochloride powder for reconstitution and injection 5mg and 10mg ampoules |
Scotland |
15/04/2021 |
Medicine Supply Alert Notice: Voriconazole (VFEND®) 40mg/ml powder for oral suspension |
Scotland |
15/04/2021 |
Medicine Supply Alert Notice: Rifinah® 300mg/150mg (rifampicin 300mg/isoniazid 150mg) tablets |
Scotland |
15/04/2021 |
COVID-19 – MHRA ADVICE – VACCINE ASTRAZENECA AND THROMBOEMBOLIC
EVENTS WITH CONCURRENT LOW PLATELETS – REVISIONS TO PRODUCT
INFORMATION |
Scotland |
12/04/2021 |
CMO messaging: COVID-19 Therapeutic Alert – Inhaled Budesonide for Adults (50 Years and Over) with COVID-19 |
UK |
31/03/2021 |
Medicine Supply Alert Notice: H2-antagonists (cimetidine, famotidine and nizatidine) |
Scotland |
31/03/2021 |
Medicine Supply Alert Notice: Oral Contraceptive tablets (various brands) |
Scotland |
23/03/2021 |
Medicine Supply Alert Notice: Irbesartan/hydrochlorothiazide 150mg/12.5mg tablets |
Scotland |
23/03/2021 |
Medicine Supply Alert Notice: Enalapril 5mg tablets |
Scotland |
18/03/2021 |
Class 4 Medicines Defect Information: Caffeine Citrate Solution for Injection 10mg/ml, Macarthys Laboratories Limited T/A Martindale Pharma |
UK |
16/03/2021 |
Medicine Supply Alert Notice: Repaglinide tablets 1mg and 2mg |
Scotland |
15/03/2021 |
Class 3 Medicines Recall: Itraconazole Oral Solution 10mg/ml, Thame Laboratories, EL (21)A/08 |
UK |
12/03/2021 |
CMO messaging: Updated information for clinicians/health care professionals on Covid-19 PCR testing |
England |
09/03/2021 |
Class 4 Medicines Defect Information: Diazepam Oral Solution Sugar Free 2mg/5ml (EL (21)A/07) (PL 0142/0103), Accord-UK Ltd |
UK |
08/03/2021 |
Medicine Supply Alert Notice: Colestid® (colestipol) orange and plain 5g granules sachets |
Scotland |
08/03/2021 |
Medicine Supply Alert Notice: Desmopressin (Octim®) 150 micrograms per actuation nasal spray (Ferring Pharmaceuticals) – update to MSAN(2020)95 |
Scotland |
08/03/2021 |
Medicine Supply Alert Notice: Docusate sodium 100mg capsules – update MSAN(2020)119 |
Scotland |
08/03/2021 |
Medicine Supply Alert Notice: Fluoxetine 10mg tablets – update to MSAN(2020)16 |
Scotland |
08/03/2021 |
Medicine Supply Alert Notice: Sancuso® (granisetron) 3.1mg/24 hours transdermal patches |
Scotland |
05/03/2021 |
Medicine Supply Alert Notice: Morphine sulphate (MST CONTINUS®) 20mg, 30mg, 60mg, 100mg and 200mg prolonged release granules for oral suspension |
Scotland |
04/03/2021 |
CAS alert: Changes to MHRA Drug Alert titles and classifications |
UK |
04/03/2021 |
CAS alert: Repaglinide tablets 1mg and 2mg – Supply Disruption |
England |
02/03/2021 |
Medicine Supply Alert Notice: Acetazolamide SR capsules 250mg |
Scotland |
02/03/2021 |
Medicine Supply Alert Notice: Fluoxetine capsules 40mg |
Scotland |
01/03/2021 |
Serious Shortage Protocol: Levothyroxine tablets 12.5 microgram |
Scotland |
01/03/2021 |
Class 3 Medicines Recall: Easyhaler Salbutamol Sulfate 100 micrograms per actuation/200 micrograms per actuation inhalation powder, EL (21)A/06 |
UK |
26/02/2021 |
CAS alert – Discontinuation of Morphine sulphate (MST CONTINUS) 20mg, 30mg, 60mg, 100mg and 200mg prolonged release granules for oral suspension |
England |
24/02/21 |
CAS alert – Class 1 Recall: Fang Tian FT-045A FFP3 masks RECALL – Immediate Action Required |
UK |
23/02/2021 |
Medicine Supply Alert Notice: Phyllocontin® (Aminophylline) modified release tablets 225mg and 350mg |
Scotland |
18/02/2021 |
CAS alert – Class 1: Fang Tian FT-045A FFP3 masks – Immediate Action Required |
UK |
17/02/2021 |
CMO Messaging: Interleukin-6 Inhibitors (Tocilizumab Or Sarilumab) For Hospitalised Patients With Covid-19 Pneumonia (Adults) |
UK |
17/02/2021 |
Class 3 Medicines Recall: SyriMed, Clonidine hydrochloride 50micrograms/5ml Oral Solution, EL (21)A/05 |
UK |
16/02/2021 |
Class 2 Medicines Recall: Eaststone Limited, MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution, EL (21)A/04 |
UK |
12/02/2021 |
CAS alert: Phyllocontin (Aminophylline) 225mg and 350mg modified release tablets (update on SDA/2021/003 issued on 9 February 2021) – Supply disruption |
England |
12/02/2021 |
CMO messaging: Colchicine in the Management of COVID-19 (SARS-CoV 2) Positive Patients – Trial Use Only |
UK |
11/02/2021 |
Class 4 Medicines Defect Information: AmBisome Liposomal 50 mg Powder for dispersion for infusion, (PL 16807/0001), EL (21)A/03 |
UK |
09/02/2021 |
CAS alert: Phyllocontin (Aminophylline) 225mg and 350mg modified release tablets – Supply disruption |
England |
08/02/2021 |
Class 2 Medicines Recall: Grünenthal Ltd, Palexia 20 mg/ml Oral Solution (PL 21727/0054) |
UK |
03/02/2021 |
CAS alert: Propofol emulsion for infusion and injection (all strengths) – Supply disruption |
England |
03/02/2021 |
Class 3 Medicines Recall: Intrapharm Laboratories Ltd, Kolanticon Gel 500ml, EL (21)A/01 |
UK |
02/02/2021 |
CAS alert: Changes to MHRA Drug Alerts |
UK |
01/02/2021 |
CMO Messaging: Interleukin-6 inhibitors (tocilizumab and sarilumab) for critically ill patients with COVID-19 pneumonia (adults) |
UK |
28/01/2021 |
CMO Messaging: COVID-19 Therapeutic Alert – Antimicrobials (azithromycin and doxycycline) Not Beneficial in the Management of COVID-19 (SARS-CoV-2) Positive Patients |
UK |
18/1/2021 |
Company led medicines recall: Instanyl 100mcg nasal spray solution ( EU/1/09/531/015) |
UK |
14/1/2021 |
Supply disruption alert: Methylprednisolone powder for solution for injection (all strengths) – Supply disruption
|
England |
12/1/2021 |
CMO Messaging: Supporting doctors throughout the COVID-19 pandemic
|
England |
8/1/2021 |
COVID-19 Therapeutic Alert: Interleukin-6 inhibitors (tocilizumab or sarilumab) for patients admitted to ICU with COVID-19 pneumonia (adults) |
UK |
4/1/2021 |
CMO Messaging: Letter from the UK Chief Medical Officers regarding the UK COVID-19 vaccination programmes
|
UK |
4/1/2021 |
Supply Disruption Alert – Update: Lithium carbonate (Priadel®) 200mg and 400mg tablets |
England |
29/12/2020 |
Class 2 Medicines Recall: Sodiofolin 50mg/ml Solution for Injection 100mg/2ml, PL 11587/0005, medac GmbH (t/a medac Pharma LLP) |
UK |
29/12/2020 |
Medicine supply alert notice: Phytomenadione (Konakion MM Paediatric) 2mg/0.2ml ampoules (Cheplapharm) |
Scotland |
29/12/2020 |
Medicine supply alert notice: Zemtard® (diltiazem) 240mg XL capsules |
Scotland |
29/12/2020 |
Medicine supply alert notice: Rifadin® (rifampicin) 100mg/5ml oral suspension |
Scotland |
29/12/2020 |
Medicine supply alert notice: Dulcolax® (bisacodyl) 5mg and 10mg suppositories |
Scotland |
29/12/2020 |
Medicine supply alert notice: Docusate sodium 100mg capsules |
Scotland |
23/12/2020 |
CMO Messaging: Indemnity arrangements for the Covid-19 vaccination programme |
England |
15/12/2020 |
Class 4 Medicines Defect Information: Co-Careldopa 25mg/100mg tablets PL 20242/0028, Fairmed Healthcare GmbH |
UK |
16/12/2020 |
Class 2 Drug Alert: Zerbaxa 1g/0.5g Powder for Concentrate for Solution for
Infusion |
Scotland |
14/12/2020 |
Class 4 Medicines Defect Information: Perindopril Erbumine tablets 2mg, 4mg, 8mg – Generics [UK] Limited t/a Mylan |
UK |
08/12/2020 |
Medicine Supply Notification: Buprenorphine (Butec) 15microgram/hour patches (7-day) |
UK |
03/12/2020 |
Class 3 Medicines Recall: Simvador 10mg Tablets, Simvador 20mg Tablets, Simvador 40mg Tablets – Lupin Healthcare (UK) Limited |
UK |
30/11/2020 |
Medicine Supply Notification: Dulcolax (bisacodyl) 5mg and 10mg suppositories |
UK |
30/11/2020 |
Medicine Supply Notification: Nalcrom (sodium cromoglicate) 100mg capsules |
UK |
30/11/2020 |
Medicine Supply Notification: Sterculia (Normacol) 62% w/w granules, Sterculia & Frangula Bark (Normacol Plus) 62%/8% w/w granules |
UK |
30/11/2020 |
Medicine Supply Notification: Ferrous Fumarate 322mg/Folic Acid 350mcg (Pregaday) tablets (Recipharm) |
UK |
30/11/2020 |
Medicine Supply Notification: Oral Contraceptive tablets (various brands) |
UK |
26/11/2020 |
Class 2 Medicines Recall: Largactil 50mg/2ml Solution for Injection PL 04425/0582, Aventis Pharma Limited (t/a Sanofi) |
UK |
26/11/2020 |
Class 2 Medicines Recall: Betahistine dihydrochloride 8mg Tablets, Betahistine dihydrochloride 16mg Tablets, Kent Pharmaceuticals Ltd |
UK |
25/11/2020 |
Class 2 Medicines Recall: Abstral 200 microgram sublingual tablets PL 16508/0031, Kyowa Kirin Limited |
UK |
17/11/2020 |
Medicine supply alert notice: Dulcolax® (bisacodyl) 5mg and 10mg suppositories |
Scotland |
17/11/2020 |
Medicine supply alert notice: Trifluoperazine 1mg/5ml syrup (Advanz Pharma) |
Scotland |
12/11/2020 |
Class 2 Medicines Recall: Ancotil 2.5 g/250 ml Solution for Infusion, PL 46302/0116, Mylan UK Healthcare Ltd |
UK |
11/11/2020 |
Class 2 Medicines Recall: medac GmbH (t/a medac Pharma LLP)
Sodiofolin 50mg/ml Solution for Injection 100mg/2ml PL 11587/0005 |
UK |
09/11/2020 |
Medicine supply alert notice: Haloperidol 5mg/5ml oral solution sugar free (Thame Laboratories) |
Scotland |
09/11/2020 |
Medicine supply alert notice: Nalcrom® (sodium cromoglicate) 100mg capsules |
Scotland |
09/11/2020 |
Medicine supply alert notice: H2-antagonists (cimetidine, famotidine and nizatidine) |
Scotland |
09/11/2020 |
Medicine supply alert notice: Zonisamide capsules various strengths (Glenmark and Teva) |
Scotland |
09/11/2020 |
Medicine supply alert notice: Prednisolone 5mg Suppositories (RPH Pharmaceuticals) |
Scotland |
09/11/2020 |
Class 4 drug alert – Kolanticon gel 200ml (PL 17509/0084), Intrapharm Laboratories Limited |
UK |
07/11/2020 |
Immediate actions in response to mink-variant SARS-CoV-2 virus in Denmark |
England |
29/10/2020 |
Class 3 Medicines Recall: Theramex Ireland Ltd T/A Theramex HQ UK Ltd, AlfaD 0.25 microgram capsules |
UK |
23/10/2020 |
Medicine supply alert notice: Ferrous Fumarate 322mg/Folic Acid 350microgram (Pregaday®) tablets (Recipharm) |
Scotland |
23/10/2020 |
Medicine supply alert notice: Fluoxetine 30mg capsules (Advanz) |
Scotland |
23/10/2020 |
Medicine supply alert notice: Salazopyrin En-Tabs® (sulfasalazine) 500mg tablets |
Scotland |
21/10/2020 |
Medicine supply alert notice: Dulcolax® (bisacodyl) 5mg suppositories |
Scotland |
21/10/2020 |
Medicine supply alert notice: DDAVP® (Desmopressin) 0.01% w/v (100 micrograms/ml) intranasal solution |
Scotland |
15/10/2020 |
Medicine supply alert notice: Lithium carbonate (Priadel®) 200mg and 400mg modified release tablets |
Scotland |
14/10/2020 |
Class 3 Medicines Recall: Metoprolol 50 mg Tablets Accord Healthcare Ltd. |
UK |
14/10/2020 |
Class 2 Medicines Recall: Epilim 500mg Gastro-Resistant Tablets |
UK |
9/10/2020 |
Medicine supply alert notice: Sterculia (Normacol®) 62% w/w granules; Sterculia & Frangula Bark (Normacol Plus®) 62%/ 8% w/w granules |
Scotland |
9/10/2020 |
Medicine supply alert notice: Oral Contraceptive tablets (various brands) |
Scotland |
9/10/2020 |
Medicine supply alert notice: H2-antagonists (cimetidine, famotidine and nizatidine) |
Scotland |
9/10/2020 |
Medicine supply alert notice: Lorazepam (Ativan®) 4mg/ml Solution for injection (Pfizer) |
Scotland |
9/10/2020 |
Medicine supply alert notice: Desmopressin (Octim®) 150 micrograms per actuation nasal spray (Ferring Pharmaceuticals) |
Scotland |
6/10/2020 |
Class 2 Medicines Recall: Boots Dermacare 1% w/w Hydrocortisone Ointment (P)
|
UK |
30/9/2020 |
MHRA supply disruption alert: Remdesivir
|
England |
29/9/2020 |
Medicine supply alert notice: Tuberculosis (TB) oral agents |
Scotland |
29/9/2020 |
Medicine supply alert notice: Enalapril 20mg tablets (various suppliers) |
Scotland |
29/9/2020 |
Medicine supply alert notice: Metronidazole (Acea®) 0.75% gel (Ferndale Pharmaceuticals) |
Scotland |
29/9/2020 |
Medicine supply alert notice: Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml Nebules |
Scotland |
29/9/2020 |
Medicine supply alert notice: Zonisamide 50mg and 100mg capsules(Teva)
|
Scotland |
29/9/2020 |
Class 3 Medicines Recall: AlfaD 0.25mcg capsules and AlfaD 1mcg capsules
|
UK |
29/9/2020 |
Medicine supply alert notice: Normacol and Normacol Plus |
England and Scotland |
18/9/2020 |
MHRA alert – Important changes to MHRA alerts and amendments to CAS website |
UK |
16/9/2020 |
Class 2 FMD Medicines Recall: multiple parallel distributed medicines
|
UK |
10/9/2020 |
CMO messaging: withdrawal of PPE guidance published 17 April 2020 |
England |
10/9/2020 |
Class 4 Medicines Defect information: Zopiclone tablets |
UK |
7/9/2020 |
Class 3 Medicines Recall: Amlodipine 10mg Tablets |
UK |
3/9/2020 |
Medicine supply notice: Lithium carbonate (Priadel®) 200mg and 400mg modified release tablets |
Scotland |
1/9/2020 |
Class 4 FMD Medicines Information: Kingsley Specials Ltd |
UK |
1/9/2020 |
Class 2 Medicines Recall: Oxylan prolonged-release tablets 40mg |
UK |
27/8/2020 |
Medicine supply alert notice: Esomeprazole 40mg iv powder for solution |
Scotland |
26/8/2020 |
Medicine supply alert notice: H2-antagonists (cimetidine, famotidine and nizatidine) |
Scotland |
26/8/2020 |
Medicine supply alert notice: Oral Contraceptive tablets (various brands) |
Scotland |
26/8/2020 |
Medicine supply alert notice: Diazepam (Diazemuls®) emulsion for injection 10mg/2ml |
Scotland |
26/8/2020 |
Medicine supply alert notice: Prednisolone suppositories 5mg |
Scotland |
26/8/2020 |
Medicine supply alert notice: Nabumetone tablets 500mg |
Scotland |
26/8/2020 |
Medicine supply alert notice: Lodoxamide eye drops 01% |
Scotland |
25/8/2020 |
Drug alert: Update: Amoxicillin Sodium Powder for Solution for Injection 1g, 250mg and 500mg (Wockhardt UK Ltd) |
UK |
24/8/2020 |
Class 2 drug alert Action within 48 hours: Fasturtec powder and solvent for concentrate for solution for infusion 7.5mg/5ml (Sanofi) |
England |
21/8/2020 |
Supply disruption alert: Priadel® modified-release tablets 200mg and 400mg |
England |
18/8/2020 |
CMO Messaging: COVID-19 Research and treatment trials |
England |
14/8/2020 |
PPE dedicated supply channel important customer alert: Flosteril FLO-MED-8130 non-sterile gowns |
England |
13/8/2020 |
Drug Alert: SmofKabiven extra Nitrogen Electrolyte Free |
UK |
13/8/2020 |
NPSA alert: Steroid Emergency Card to support early recognition and treatment of adrenal crisis in adults |
England |
11/8/2020 |
Medicine supply alert notice: Pethidine 50mg tablets |
Scotland |
11/8/2020 |
Medicine supply alert notice: Sulfasalazine 250mg-5ml oral suspension (Rosemont) |
Scotland |
10/8/2020 |
Drug alert: Phosphates Solution for Infusion 500ml (Huddersfield Pharmacy Specials MS 19055) |
UK |
6/8/2020 |
NPSA alert: Risk of death from unintended administration of sodium nitrite |
England |
5/8/2020 |
Medicine supply alert notice: Tuberculosis (TB) oral agents |
Scotland |
5/8/2020 |
Medicine supply alert notice: Senna with ispaghula husk (Manevac®) granules (Mylan) |
Scotland |
5/8/2020 |
Medicine supply alert notice: Nabumetone 500mg Tablets |
Scotland |
5/8/2020 |
Medicine supply alert notice: H2-antagonists (cimetidine, famotidine and nizatidine) |
Scotland |
4/8/2020 |
Drug alert: Clexane 4,000 IU (40mg) /0.4ml Syringes (Pharmaram Ltd) |
Scotland |
4/8/2020 |
Drug alert: Clexane 4,000 IU (40mg)/0.4ml Syringes (Pharmaram Ltd) |
England, Northern Ireland and Wales |
3/8/2020 |
Medicines defect information: SyreniRing vaginal delivery system 0.120mg/0.015mg per 24 hours (Crescent Pharma Ltd)
|
UK |
3/8/2020 |
Drug recall: Digoxin tablets 250mcg (Accord-UK Ltd)
|
UK |
29/7/2020 |
Drug recall: Abstral sublingual tablets 200mcg (Kyowa Kirin Limited)
|
UK |
24/7/2020 |
Evidence of harm from illicit or fake benzodiazepines
|
England |
23/7/020 |
Drug Recall: Irinotecan hydrochloride concentrate for solution for infusion 20mg/ml (5ml vial)
|
England, Northern Ireland and Scotland |
23/7/2020 |
Drug Alert: information Ecalta 100mg powder for concentrate for solution for infusion |
England, Northern Ireland and Scotland |
21/7/2020 |
DHSC alert: cannabis oil has been found disguised as confectionary |
England |
20/7/2020 |
Drug alert: Trimogal tablets 100mg (Ennogen Pharma)
|
England and Scotland |
20/7/2020 |
Medical device alert: Cardinal Health type IIR facemasks alert
|
England |
20/7/2020 |
Drug alert: Ibuprofen 200mg and 400mg tablets packaged in various liveries (Aspar Pharmaceuticals Limited)
|
Scotland |
20/7/2020 |
Drug alert: Ibuprofen 200mg and 400mg tablets packaged in various liveries (Aspar Pharmaceuticals Limited)
|
Northern Ireland |
20/7/2020 |
Drug alert: Ibuprofen 200mg and 400mg tablets packaged in various liveries (Aspar Pharmaceuticals Limited)
|
England and Wales |
15/7/2020 |
Drug Alert: Nitrofurantoin tablets 50mg, Dr Reddy’s Laboratories (UK) Ltd (15/07/2020)
|
England, Northern Ireland and Wales |
15/7/2020 |
Drug Alert: Desmopressin nasal spray (all strengths) Ferring Pharmaceuticals Limited
|
England, Scotland and Wales |
15/7/2020 |
Drug alert: Desmospray® 0.1 mg/ml Nasal Spray
|
Northern Ireland |
8/7/2020 |
MSN: Pregaday® (ferrous fumarate 322mg/folic acid 350mcg) tablets (08/07/20)
|
England, Northern Ireland and Scotland |
8/7/2020 |
MSN: Intal® (sodium cromoglicate) CFC-free inhaler 5mg/dose (08/07/20)
|
England and Northern Ireland |
1/7/2020 |
MSN: Mitomycin 2mg |
England |
01/7/2020 |
Drug Recall: Mepacrine hydrochloride tablets 100mg |
UK |
30/6/2020 |
Drug Alert: Depo-Provera injection 150mg/ml |
England, Scotland, Northern Ireland |
30/6/2020 |
Medicine supply alert: Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml Nebules |
Scotland |
30/6/2020 |
Medical drug alert: Philips HeartStart XL Defibrillator/Monitor |
England |
29/6/2020 |
Drug safety alert: Reducing the risk of meningioma with cyproterone acetate
|
UK |
29/6/2020 |
Drug safety alert: Direct-acting oral anticoagulants (DOACs) — increased bleeding risk
|
UK |
29/6/2020 |
Medicine supply alert: Prednisolone 5mg Suppositories (RPH Pharmaceuticals) |
Scotland |
29/6/2020 |
Medicine supply alert: Promazine 25mg and 50mg tablets |
Scotland |
29/6/2020 |
Medicine supply alert: Phenytoin sodium NRIM 100mg capsules |
Scotland |
26/6/2020 |
Customer alert: Cardinal Health Type IIR masks alert
|
UK |
26/6/2020 |
MHRA approves recruitment of further participants into hydroxychloroquine clinical trial
|
UK |
25/6/2020 |
MSN: Flixotide nebules |
England |
25/06/20 |
SDA: Nardil® (Phenelzine sulphate) tablets 15mg (25/06/20) |
England, Northern Ireland, Wales |
25/06/20 |
MSN: Mirtazapine orodispersible tablets 15mg and 45mg |
UK |
25/6/2020 |
MSN: Alomide® (lodoxamide) eye drops 0.1% |
England, Northern Ireland, Scotland |
25/6/2020 |
MSN: Imipramine tablets 25mg |
UK |
25/6/2020 |
MSN: Vimpat® (lacosamide) tablets 50mg |
England |
23/6/2020 |
CAS alert: risk of heat stress whilst wearing PPE in warn/hot weather |
England |
19/6/2020 |
Medicine supply alert: H2-antagonists (cimetidine, famotidine and nizatidine) |
Scotland |
18/6/2020 |
MSN TB oral agents Update 7 |
England |
17/6/2020 |
Medical device alert: Philips HeartStart MRx Monitor/Defibrillators |
England |
16/6/2020 |
MSN: levodopa +carbidopa+ entacapone tablets- various strengths and brands |
England |
16/6/2020 |
CAS alert: Dexamethasone approved to treat hospitalised COVID-19 patients |
UK |
12/6/2020 |
MSN: Ranitidine- all formulations (clinical update) |
England |
12/6/2020 |
MSN: oxaliplatin Update |
England |
10/6/2020 |
MSN: Prednisolone 5mg Suppositories |
England |
9/6/2020 |
Second update – Early Access to Medicines Scheme for Remdesivir in the treatment of COVID-19. Implementation of the scheme and management of supply |
UK |
8/6/2020 |
MSN: Solu-Medrone 1g |
England |
8/6/2020 |
MHRA medical device alert (8/6/20) ISSUED: Results from laboratory-based tests for COVID-19 antibodies using capillary blood sample collection kits may not be reliable (MDA/2020/015) |
UK |
8/6/2020 |
Drug alert: Epistatus (Midazolam) 10mg/mL Oromucosal Solution (multi Dose Bottle) |
England |
3/6/2020 |
Update – Early Access to Medicines Scheme for remdesivir in the treatment of COVID-19. Implementation of the scheme and management of supply |
UK |
29/5/2020 |
MSN fluoxetine 40mg capsules |
England |
29/5/2020 |
MSN: Caffeine Citrate 10mg in 1ml oral solution |
England |
29/5/2020 |
SDA: Zyban prolonged release tablets 150mg |
England |
29/5/2020 |
SDA: Danazol capsules 100mg and 200mg |
England |
28/5/2020 |
Medicines Defect information: Sodium benzoate sterile solution for injection 2g/10ml |
England |
27/5/2020 |
Company led recall – Duavive modified release tablets |
England |
26/5/2020 |
Early Access to Medicines Scheme for remdesivir in the treatment of COVID-19 |
UK |
25/5/2020 |
SDA: Diamorphine hydrochloride 5mg and 10mg injection |
England |
22/5/2020 |
SDA Update- Neuromuscular blocking agents: atracurium, cisatracurium and rocuronium |
England |
18/5/2020 |
COVID-19 General Case Definition Change |
UK |
18/5/2020 |
CAS alert: ending the prescribing and supply of antiviral medicines in primary care for the influenza season 2019/20 |
UK |
18/5/2020 |
Medicines Recall – Emerade injection 500mcg |
England |
13/5/2020 |
SDA: Salazopyrin suppositories 500mg |
England |
10/5/2020 |
CAS alert: Tiger Eye Protector Product – removal from the supply chain in respect of COVID-19 use |
England |
7/5/2020 |
SDA: Phosphate polyfusor 500ml |
England |
5/5/2020 |
CAS alert: COVID-19 Yellow Card reporting site launched by MHRA |
UK |
6/5/2020 |
CAS alert: Recruiting patients for clinical trials for COVID-19 therapeutics |
England |
1/5/2020 |
CAS alert: Message from the UK CMOs and Medical Directors of Public Health England and NHS England |
England |